Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cra International (CRAI) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Cra International (CRAI) over the last 10 years, with Q3 2025 value amounting to $155000.0.

  • Cra International's Asset Writedowns and Impairment rose 26489.36% to $155000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $665000.0, marking a year-over-year increase of 1139.03%. This contributed to the annual value of $534000.0 for FY2024, which is 18.76% up from last year.
  • Cra International's Asset Writedowns and Impairment amounted to $155000.0 in Q3 2025, which was up 26489.36% from $130000.0 recorded in Q2 2025.
  • Over the past 5 years, Cra International's Asset Writedowns and Impairment peaked at $921000.0 during Q1 2022, and registered a low of -$141000.0 during Q3 2022.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $18000.0 (2024), whereas its average is $156533.3.
  • As far as peak fluctuations go, Cra International's Asset Writedowns and Impairment plummeted by 83076.92% in 2022, and later skyrocketed by 62222.22% in 2025.
  • Cra International's Asset Writedowns and Impairment (Quarter) stood at -$13000.0 in 2021, then tumbled by 538.46% to -$83000.0 in 2022, then surged by 112.05% to $10000.0 in 2023, then crashed by 630.0% to -$53000.0 in 2024, then soared by 392.45% to $155000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $155000.0 for Q3 2025, versus $130000.0 for Q2 2025 and $433000.0 for Q1 2025.